G. Ciprandi, L. M. Bellussi, V. Damiani, and D. Passali, “HMGB1-antagonism exerted by glycyrrhizin could be fruitful against COVID-19. ”, Acta Biomed, vol. 92, no. S6, p. e2021455, Oct. 2021, doi: 10.23750/abm.v92iS6.12111.